📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. (2019)

First Author: Jakubowska MA

Attributed to: MICA: Calcium signalling, organelle dysfunction and pancreatitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.14505

PubMed Identifier: 30266036

Publication URI: http://europepmc.org/abstract/MED/30266036

Type: Journal Article/Review

Volume: 176

Parent Publication: British journal of pharmacology

Issue: 22

ISSN: 0007-1188